The role of adjuvant chemotherapy in patients with thymoma and thymic carcinoma following surgery: a systematic literature review and meta-analysis
Notably, POCT did not have a significant impact on DFS in patients with thymoma or thymic carcinoma. These findings suggest that postoperative adjuvant chemotherapy may not be necessary for advanced thymoma patients but can be beneficial for those with thymic carcinoma.
Authors
- Yingqi Xu (ORCID: https://orcid.org/0000-0001-6879-639X)
- Minghui Yang
- Pasan Witharana (ORCID: https://orcid.org/0000-0001-9891-2486)
- William Chi Shing Cho (ORCID: https://orcid.org/0000-0003-4174-4586)
- Sikai Wu (ORCID: https://orcid.org/0009-0009-7450-7588)
- Yuyang Li (ORCID: https://orcid.org/0000-0002-5589-1029)
- Congcong Xu
- Jianfei Shen (ORCID: https://orcid.org/0000-0001-6123-0959)
- Chengchu Zhu
Institutions
- Donghua University (CN)
- Wenzhou Medical University (CN)
- Taizhou Central Hospital (CN)
- Queen Elizabeth Hospital (CN)
- Imperial College London (GB)
- Taizhou University (CN)
Publication Details
- Journal
- Journal of Thoracic Disease
- Published
- 2025-10-01
- DOI
- https://doi.org/10.21037/jtd-2025-1157
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 0.00